文献速递妇科

美国印第安人/阿拉斯加原住民女性宫颈癌持续差异:我们是否充分利用了预防工具?

Persistent disparities of cervical cancer among American Indians/Alaska natives: Are we maximizing prevention tools?
PubMed 文献 · Gynecol Oncol · 2022-11-15

该研究利用印第安人卫生服务(IHS)国家数据仓库中2010至2020年太平洋西北地区所有就诊记录,评估21至64岁女性巴氏涂片筛查及9至26岁人群HPV疫苗接种情况;结果显示筛查率在57.1%至65.0%之间,低于全国平均73.5%,HPV疫苗接种率58.6%,远低于健康人民2030目标84.3%。

要点

  • 太平洋西北地区印第安人/阿拉斯加原住民女性宫颈癌筛查率为57.1%至65.0%,低于全国平均73.5%。
  • 50至64岁年龄组巴氏涂片筛查及时率显著更低。
  • HPV疫苗接种率随时间上升,但当前58.6%仍远低于健康人民2030目标84.3%。

核心结论

  • 宫颈癌筛查和HPV疫苗接种是预防和早期发现宫颈癌的基石,但这些工具在印第安人/阿拉斯加原住民中利用不足,可加强公共卫生努力以改善该人群宫颈癌差异。

研究设计与样本

  • 分析印第安人卫生服务(IHS)国家数据仓库Epi Data Mart中2010至2020年太平洋西北地区IHS、部落和城市印第安诊所的所有就诊记录。
  • 纳入21至64岁女性;巴氏涂片及时定义为最近临床就诊前3年内细胞学检查或5年内细胞学联合HPV检测。
  • 计算9至26岁男女HPV疫苗接种率;完成接种定义为15岁前接种两剂或15岁后启动接种三剂。

主要发现

  • 宫颈癌筛查率在57.1%至65.0%之间,低于全国平均73.5%。
  • 年龄亚组分析显示50至64岁组巴氏涂片及时筛查率显著更低。
  • 所有年龄组男女HPV疫苗接种率随时间上升,但当前接种率58.6%远低于健康人民2030目标84.3%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cervical cancer incidence and mortality disparities experienced by American Indian/Alaska Native (AI/AN) women have persisted for decades. Pap smear screening and HPV vaccination are powerful tools to prevent cervical cancer. We evaluated the utilization of these tools among AI/ANs living in the Pacific Northwest (PNW). METHODS: The Indian Health Service (IHS) National Data Warehouse's Epi Data Mart was analyzed using all healthcare visits from 2010 to 2020 from IHS, Tribal, and Urban Indian clinics in the PNW. Women ages 21-64 were included and considered up-to-date on pap smears if they had either cytology within 3 years or cytology with HPV testing within 5 years of the most recent clinical encounter. HPV vaccination rates for both sexes were calculated for individuals ages 9-26. HPV vaccination was considered complete if: two vaccines were received prior to age 15 or after three vaccinations if initiated after age 15. FINDINGS: Cervical cancer screening rates are below the national average of 73.5% ranging between 57.1% - 65.0%. Sub-analysis of age groups shows substantially lower rates of up-to-date pap smear screening in the 50-64 age group. HPV vaccination rates have increased over time for both sexes across all age groups. However, the current vaccination rate of 58.6% is well below the Healthy People 2030 goal of 84.3%. INTERPRETATION: Cervical cancer screening and HPV vaccination are the cornerstones of cervical cancer prevention and early detection. These tools are underutilized and public health efforts can be strengthened to improve cervical cancer disparities in AI/AN women. FUNDING: Author ASB: Funding for this project has been provided through the Robert Wood Johnson Foundation Harold Amos Minority Faculty Development Grant and the National Cancer Institute K08 Mentored Clinical Scientist Development Award.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Bruegl AS, Emerson J, Tirumala K, et al. Persistent disparities of cervical cancer among American Indians/Alaska natives: Are we maximizing prevention tools? Gynecol Oncol. 2022. PMID: 36399813. doi:10.1016/j.ygyno.2022.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。